BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 8465483)

  • 21. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
    Ohsato K; Okamoto K
    Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.
    Bots ML; Breteler MM; van Kooten F; Haverkate F; Meijer P; Koudstaal PJ; Grobbee DE; Kluft C
    Haemostasis; 1998; 28(3-4):216-22. PubMed ID: 10420069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical experiences of renal and upper ureter stone by extracorporeal shock wave lithotripsy (ESWL). II: 3-month follow-up of cases treated with ESWL].
    Kato S; Tanda H; Ohnishi S; Saka T; Nakajima H
    Hinyokika Kiyo; 1985 Aug; 31(8):1317-20. PubMed ID: 4083195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study of extracorporeal shock wave lithotripsy for 1000 patients with renal and ureteral stones].
    Eto H; Harada M; Okuda Y; Maeda H; Fujisawa M; Fujii A; Ka S; Hamaguchi T; Gohji K; Kamidono S
    Hinyokika Kiyo; 1990 Aug; 36(8):887-91. PubMed ID: 2239589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Place of extracorporeal shock-wave lithotripsy (ESWL) in management of cystine calculi.
    Katz G; Lencovsky Z; Pode D; Shapiro A; Caine M
    Urology; 1990 Aug; 36(2):124-8. PubMed ID: 2385879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
    Madoiwa S
    Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
    [No Abstract]   [Full Text] [Related]  

  • 27. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
    Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y
    Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulopathy associated with residual dissection after surgical treatment of type A aortic dissection.
    Nakajima T; Kin H; Minagawa Y; Komoda K; Izumoto H; Kawazoe K
    J Vasc Surg; 1997 Oct; 26(4):609-15. PubMed ID: 9357461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between clinical signs and hypercoagulable state in toxemia of pregnancy.
    Terao T; Maki M; Ikenoue T; Gotoh K; Murata M; Iwasaki H; Shibata J; Nakabayashi M; Muraoka M; Takeda Y
    Gynecol Obstet Invest; 1991; 31(2):74-85. PubMed ID: 1828053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of thrombin-antithrombin III complex and plasmin-alpha 2 plasmin inhibitor complex in chronic liver diseases].
    Ohmoto K; Yamamoto S; Ideguchi S; Yamamoto R; Takatori K; Ohumi T; Hino K; Hirano Y
    Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1837-45. PubMed ID: 2147451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
    Koike K; Fujimaki M
    Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating prethrombotic state in lung cancer using molecular markers.
    Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Chest; 1993 Jan; 103(1):196-200. PubMed ID: 7678080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
    Kanamori N; Koiwa F; Uda S
    Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experience with extracorporeal shock wave lithotripsy (ESWL) in upper urinary tract stones].
    Ben A; Kudo T; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1988 Jan; 34(1):73-8. PubMed ID: 3376807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of acute endocrine pancreatic injury as collateral damage of shock-wave lithotripsy for upper urinary tract stones.
    Wendt-Nordahl G; Krombach P; Hannak D; Häcker A; Michel MS; Alken P; Knoll T
    BJU Int; 2007 Dec; 100(6):1339-43. PubMed ID: 17979932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

  • 38. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
    Tohgi H; Takahashi H; Chiba K; Tamura K
    Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of new coagulation and fibrinolytic markers in ischemic stroke patients.
    Ono N; Koyama T; Suehiro A; Oku K; Fujikake K; Kakishita E
    Stroke; 1991 Nov; 22(11):1369-73. PubMed ID: 1836283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
    Yamada S; Asakura H
    Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.